Home MarketXLS
Dashboard MarketXLS
Screener MarketXLS
Options Profit Calculator MarketXLS
Stock Ranks MarketXLS
Spreadsheet Builder MarketXLS
Documentation MarketXLS
Logout MarketXLS
Ligand Pharmaceuticals Incorporated logo

Ligand Pharmaceuticals Incorporated

Sector: Healthcare   

Industry: Biotechnology

80.06
 
USD
  
-1.28
  
(-0.01573642)
Optionable: Yes  Market Cap: 1438888605.0  90-day average vol: 144790.0

Previous close: 81.34  Open: 81.04  Bid: 75.0  Ask: 85.0
52 week range    
49.24   
   94.57
Last updated: Sunday 16th June 2024

Get Access to 1 Billion Usable Market data points IN YOUR EXCEL SHEETS WITH EASY TO USE EXCEL FUNCTIONS

Get started today
Search for a stock

🎉 Exciting news! 🎉

You are invited to join our Discord Channel.

Interact, learn, and grow with experts in the markets!

Join our Discord

Metrics

Valuation

10.958

2.05

83.0

39.02

NA , NA

Returns

0.006664151892367674

-0.058339214302516984

0.1097865261990574

0.02601563501217482

0.02504878136219076

0.15223755148800694

0.12097451694203305

Risk

0.9858

1.0745

Ranks

65.0

30.0

Dividends

0.0

2007-04-19

0.0

0.0

Analyst Estimates

3.54

4.6

0.9

0.82

116.33

116.33

116.33

116.33

Financial Health

2.76

14.2

12.1

0.01

0.32

Technicals

45.8990620968

82.6564285714

81.9112

57.7845616132

2.97543766705

79.7992

69.39085

19.07131035

2.3880419166

Growth

Profitability

6.73

49.0

8.03

7.57

112.5

92.0

Peers

StockDividendMarket Cap (B)PEPrice ($)
Financials

LGND Income Statement

Annual
Dec-13Dec-14Dec-15Dec-16Dec-17Dec-18Dec-19Dec-20Dec-21Dec-22
Amortization of intangibles-2 M-2 M-2 M-11 M-11 M-16 M210 M595 M106 M106 M
Basic EPS from continuing operations0.270.378.11-0.070.374.2220.67-0.112.15-0.31
Basic EPS total20.67-0.112.15-1.98
Basic weighted shares outstanding33 M33 M32 M33 M34 M34 M30 M26 M27 M17 M
BasicDiscontinuousOperations0.080.02-1.67
Cost of sales-6 M-9 M-6 M-6 M-5 M6 M11 M30 M62 M53 M
Depletion47 M
Depreciation-3 M-300000.0-200000.0-200000.0-400000.0-900000.02 M2 M2 M4 M
Depreciation unreconciled2 M11 M12 M16 M23 M47 M
DepreciationAndAmortization-3 M-300000.02 M11 M12 M16 M2 M2 M2 M4 M
Diluted EPS total19.87-0.112.06-1.98
Diluted normalized net income/share0.270.357.56-0.070.333.7219.87-0.112.06-0.31
Diluted weighted shares outstanding33 M34 M34 M33 M38 M39 M32 M26 M28 M17 M
DilutedDiscontinuousOperations0.070.02-1.67
Earnings from equity interest-5 M-23 M-2 M
EarningsFromEquityInterestNetOfTax-5 M-23 M-2 M
ExciseTaxes17 M
GainOnSaleOfBusiness1 M
GainOnSaleOfSecurity3 M5 M28 M12000.050 M1 M-17 M-5 M29 M
GainsLossOnDisposalOfDiscontinuedOperations3 M731000.0
GeneralAndAdministrativeExpense18 M23 M24 M28 M29 M38 M42 M64 M47 M70 M
Gross operating profit43 M55 M66 M103 M136 M245 M109 M156 M179 M143 M
ImpairmentOfCapitalAssets-5000.016000.017 M
Income before tax9 M11 M35 M8 M57 M173 M797 M-11 M72 M36 M
Income restructuring and M&A560000.01 M1 M1 M
Income taxes374000.0410000.0-192 M10 M45 M30 M167 M-8 M-4 M41 M
Interest income14 M28 M8 M886000.02 M
InterestExpenseNonOperating-2 M778000.013 M48 M36 M27 M20 M2 M
MarketingExpense23 M
MinorityInterests1 M2 M767 M
MiscOtherSpecialCharges-63000.02 M2 M3 M3 M-6 M809 M17 M-8 M4 M
Net income from total operations11 M12 M230 M-3 M13 M143 M629 M-3 M57 M-33 M
NetIncomeCommonStockholders11 M12 M230 M-3 M13 M143 M629 M-3 M76 M-5 M
NetIncomeContinuousOperations11 M12 M230 M-3 M13 M143 M629 M-3 M57 M-33 M
NetIncomeDiscontinuousOperations3 M731000.0-19 M-28 M
NetIncomeExtraordinary-2 M13 M
NetNonOperatingInterestIncomeExpense2 M-778000.0-13 M-34 M-7 M-19 M-19 M247000.0
NetOperatingInterestIncomeExpense-2 M-5 M-12 M-12 M-11 M
Normalized income102 M28 M
Operating income16 M21 M28 M44 M68 M164 M807 M26 M104 M3 M
Operating income before depreciation (EBITDA)10 M18 M48 M31 M94 M275 M896 M69 M160 M90 M
OperatingExpense-34 M-45 M-45 M-65 M-73 M-88 M126 M178 M138 M193 M
Other income net4 M3 M-20 M24 M-3 M-44 M-810 M-73000.047 M-33 M
Other special charges-38 M
OtherGainLossFromDispositionOfDiscontinuedOperations-19 M-28 M
OtherGandA18 M23 M24 M28 M29 M38 M42 M64 M47 M70 M
OtherImpairmentOfCapitalAssets34 M
OtherOperatingExpenses-417000.0-40000.0-154000.0-70000.0-1 M-1 M-543000.0-4 M-38 M-58000.0
RentAndLandingFees18 M23 M24 M28 M29 M38 M
Research & development expense10 M12 M11 M21 M27 M28 M56 M59 M32 M36 M
ResearchExpense10 M12 M11 M21 M27 M28 M56 M59 M32 M36 M
RestructringAndMnAIncome560000.01 M1 M1 M
Revenue per share-2 M-2 M2 M11 M12 M16 M210 M595 M140 M140 M
SalariesAndWages-6 M-11 M-12 M-19 M-25 M-21 M25 M31 M29 M34 M
Selling Gen & administrative expense18 M23 M24 M28 M29 M38 M42 M88 M47 M70 M
SellingAndMarketingExpense23 M
Special income/charges-560000.0-1 M-1 M-1 M-17 M38 M
Total Income available for interest expense (EBIT)7 M12 M35 M8 M71 M222 M832 M17 M92 M38 M
Total common shares outstanding33 M31 M33 M34 M34 M33 M26 M27 M27 M17 M
Total net income11 M12 M230 M-3 M13 M143 M629 M-3 M57 M-33 M
Total ordinary shares18 M18 M18 M18 M18 M18 M18 M18 M18 M18 M
Total revenues49 M65 M72 M109 M141 M251 M120 M186 M242 M196 M
TotalExpenses-40 M-54 M-50 M-71 M-78 M-81 M137 M208 M200 M246 M
TotalRevenue19 M28 M28 M23 M141 M251 M120 M186 M242 M196 M
Call: 1-877-778-8358
Ankur Mohan MarketXLS
Welcome! I'm Ankur, the founder and CEO of MarketXLS. With more than ten years of experience, I have assisted over 2,500 customers in developing personalized investment research strategies and monitoring systems using Excel.

I invite you to book a demo with me or my team to save time, enhance your investment research, and streamline your workflows.
Implement “your own” investment strategies in Excel with thousands of MarketXLS functions and templates.

MarketXLS is a complete Excel stock solution

Kevin Hsu

StockKevin.com

I have used lots of stock and option information services. This is the only one which gives me what I need inside Excel

Lloyd Lenase

Option Day Trader

MarketXLS is a data junkie’s dream. It gives me the flexibility to mine for hidden treasures.

Dave

Swing trader since 2011

I like to access historical closing prices on a particular date. That makes tracking performance easy.

Patrick Cusatis, Ph.D., CFA

Associate Professor of Finance - Penn State University